We are live on ! Find out more
OHS

Odey Holdings (Switzerland) Portfolio holdings

AUM $11.1M
1-Year Est. Return 64.12%
This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+64.12%
3 Year Est. Return
+103.95%
5 Year Est. Return
+271.11%
10 Year Est. Return
–
AUM
$1.39M
AUM Growth
+$221K
Cap. Flow
+$157K
Cap. Flow %
11.3%
Top 10 Hldgs %
68.54%
Holding
24
New
3
Increased
8
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$53.5K
2
BMCH
BMC Stock Holdings, Inc
BMCH
+$34.9K
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$33.2K
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$32.4K
5
AAPL icon
Apple
AAPL
+$20.7K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$73K
2
BIIB icon
Biogen
BIIB
+$26K

Sector Composition

Rank Sector Weight
1 Technology 28.35%
2 Communication Services 20.27%
3 Consumer Discretionary 18.11%
4 Financials 15.3%
5 Healthcare 14.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
META icon
1
Meta Platforms (Facebook)
META
$1.42T
$160K 11.54%
1,060
+54
+5% +$8.03K
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.36T
$121K 8.73%
2,600
+400
+18% +$18.7K
LRCX icon
3
Lam Research
LRCX
$367B
$115K 8.3%
8,100
+730
+10% +$10.7K
BKNG icon
4
Booking.com
BKNG
$149B
$110K 7.94%
1,475
– –
AAPL icon
5
Apple
AAPL
$4.54T
$92K 6.64%
2,560
+560
+28% +$20.7K
AVGO icon
6
Broadcom
AVGO
$1.85T
$91K 6.57%
3,900
+600
+18% +$13.9K
REGN icon
7
Regeneron Pharmaceuticals
REGN
$78.5B
$73K 5.27%
148
+74
+100% +$32.4K
DFS
8
DELISTED
Discover Financial Services
DFS
$66K 4.76%
1,055
– –
ATVI
9
DELISTED
Activision Blizzard
ATVI
$63K 4.55%
1,100
+325
+42% +$17.9K
BAC icon
10
Bank of America
BAC
$435B
$59K 4.26%
2,420
– –
ALXN
11
DELISTED
Alexion Pharmaceuticals
ALXN
$56K 4.04%
+460
New +$53.5K
GS icon
12
Goldman Sachs
GS
$300B
$53K 3.82%
240
– –
RCL icon
13
Royal Caribbean
RCL
$85.1B
$40K 2.89%
370
– –
VRTX icon
14
Vertex Pharmaceuticals
VRTX
$121B
$36K 2.6%
+276
New +$33.2K
BMCH
15
DELISTED
BMC Stock Holdings, Inc
BMCH
$35K 2.53%
+1,600
New +$34.9K
AMZN icon
16
Amazon
AMZN
$2.92T
$34K 2.45%
700
– –
MTG icon
17
MGIC Investment
MTG
$6.16B
$34K 2.45%
3,000
– –
BMY icon
18
Bristol-Myers Squibb
BMY
$133B
$32K 2.31%
575
– –
MSFT icon
19
Microsoft
MSFT
$3.45T
$32K 2.31%
470
– –
TRIP icon
20
TripAdvisor
TRIP
$1.65B
$32K 2.31%
850
+280
+49% +$11.6K
KGC icon
21
Kinross Gold
KGC
$27.4B
$28K 2.02%
7,000
– –
WPM icon
22
Wheaton Precious Metals
WPM
$49.5B
$24K 1.73%
1,200
– –
BIIB icon
23
Biogen
BIIB
$30B
– –
-95
Closed -$26K
CELG
24
DELISTED
Celgene Corp
CELG
– –
-590
Closed -$73K

Similar funds

LW
LLR Walnut Philadelphia, Pennsylvania $10M AUM 71.21% 1-Year Est. Return
PCG
Park Capital Group Redondo Beach, California $8.62M AUM
AGEC
Ark Global Emerging Companies Salt Lake City, Utah $14M AUM
WSC
White Square Capital London, United Kingdom $14.7M AUM 151.72% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
EFM
Ennismore Fund Management London, United Kingdom $71.7M AUM 92.16% 1-Year Est. Return
NI
Northwood Investors Denver, Colorado $73.8M AUM

Odey Holdings (Switzerland)'s Q2 2017 Portfolio in Review

As of Q2 2017, Odey Holdings (Switzerland) held 24 positions worth $1.39M, up 19% from $1.17M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Odey Holdings (Switzerland) deployed $157K of net new capital in Q2 2017, opening 3 new positions and adding to 8 existing holdings. Its largest new stake was Alexion Pharmaceuticals: 460 shares worth $56K.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the most notable exit was Celgene Corp, an estimated $73K sold.

  • Odey Holdings (Switzerland)'s largest Q2 2017 buy was Alexion Pharmaceuticals: 460 shares worth $56K.
  • Odey Holdings (Switzerland) added most to Regeneron Pharmaceuticals in Q2 2017, an estimated $32.4K increase.
  • Odey Holdings (Switzerland) fully exited Celgene Corp in Q2 2017, selling an estimated $73K.
  • Odey Holdings (Switzerland)'s ten largest holdings make up 69% of its $1.39M portfolio in Q2 2017.
  • Odey Holdings (Switzerland) opened 3 new positions and closed 2 in Q2 2017.
  • Odey Holdings (Switzerland)'s portfolio value rose 19% quarter-over-quarter to $1.39M.

Based on Odey Holdings (Switzerland)'s 13F filing for Q2 2017, filed 14 Aug 2017.